The aim is to describe the study protocol of a randomized controlled trial testing E-nergEYEze.
ID
Source
Brief title
Condition
- Vision disorders
Synonym
Health condition
Research involving
Sponsors and support
Intervention
- Psychosocial intervention
Outcome measures
Primary outcome
Fatigue severity will be measured with the Fatigue Severity (FS) subscale of the Checklist Individual Strenghts (CIS)
Secondary outcome
Adaptation to vision loss, symptoms of depression, anxiety, vision-related quality of life, work functioning and work participation, need for recovery, sleep disorder, health care utilisation, medication use, absenteeism and presenteeism from paid and unpaid work, health-related quality of life.
Background summary
negative impact on daily life. Since there is no evidence-based treatment to reduce fatigue in adults with visual impairment, we developed E-nergEYEze, an eHealth intervention based on cognitive behavioral therapy and selfmanagement tailored to the needs of visually impaired adults.
Study objective
Study design
face session and a computer training followed by internet-based modules with information and assignments on coping with fatigue. During this 5-month intervention, participants will be digitally supported by a social worker. All measurements will be administered at baseline, after 6 and 12 months, and additionally, those related to costeffectiveness at 3 and 9 months. The primary outcome is fatigue severity (CIS-FS).
Intervention
Age
Inclusion criteria
cause (ophthalmic disorder)
➤ Being 18 years or older
➤ Understanding of the Dutch language
➤ Experiencing severe fatigue (CIS-FSa-score > 35) [30]
➤ Having access to the internet
Exclusion criteria
➤ Experiencing severe cognitive limitations assessed with the 6-item
screener (short validated MMSEb)
➤ Currently receiving treatment, or having received treatment in the
last 12 months by a medical specialist for a comorbid disease that
clearly is the main cause of fatigue (MS, cancer, psychiatric disorder).
Design
Recruitment
IPD sharing statement
Kamer G4-214
Postbus 22660
1100 DD Amsterdam
020 566 7389
mecamc@amsterdamumc.nl
Followed up by the following (possibly more current) registration
Other (possibly less up-to-date) registrations in this register
No registrations found.
In other registers
Register | ID |
---|---|
NTR-new | NL7764 |
CCMO | NL67802.029.18 |
OMON | NL-OMON52602 |